BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8901986)

  • 1. Clinical aspects of treatment with platelet concentrates.
    Lanzer G
    Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a freshly prepared thrombocyte mass in thrombocytopenic hemorrhages].
    Baĭdurin SA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):33-9. PubMed ID: 7367409
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, immunologic, and technical factors affecting recovery of platelet count after platelet transfusion.
    Inverardi D; Bocchio C; Rossi L; Mazzucco L; De Paoli L; Borzini P
    Haematologica; 2002 Aug; 87(8):893-4. PubMed ID: 12161372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transfusion.
    Machin SJ; Kelsey H; Seghatchian MJ; Warwick R; Mackie IJ
    Thromb Haemost; 1995 Jul; 74(1):246-52. PubMed ID: 8578466
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet dosing.
    Schlossberg HR; Herman JH
    Transfus Apher Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12725947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic platelet transfusions.
    Valeri CR; Ragno GM
    N Engl J Med; 2010 Jun; 362(22):2141; author reply 2141-2. PubMed ID: 20527061
    [No Abstract]   [Full Text] [Related]  

  • 11. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A consistent approach to platelet transfusion in the NICU.
    Del Vecchio A; Motta M; Radicioni M; Christensen RD
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood bank physician as a hemostasis consultant.
    Sweeney JD
    Transfus Apher Sci; 2008 Oct; 39(2):145-50. PubMed ID: 18760674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood component therapy in the treatment of platelet disorders.
    Eisenstaedt R
    Semin Hematol; 1986 Jan; 23(1):1-7. PubMed ID: 3511534
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion: basic aspects.
    Holbro A; Infanti L; Sigle J; Buser A
    Swiss Med Wkly; 2013; 143():w13885. PubMed ID: 24338781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet transfusion: products, indications, dose, threshold and efficacy].
    Andreu G; Vasse J; Tardivel R; Semana G
    Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial contamination in platelet concentrates.
    Pietersz RN; Reesink HW; Panzer S; Oknaian S; Kuperman S; Gabriel C; Rapaille A; Lambermont M; Deneys V; Sondag D; Ramírez-Arcos S; Goldman M; Delage G; Bernier F; Germain M; Vuk T; Georgsen J; Morel P; Naegelen C; Bardiaux L; Cazenave JP; Dreier J; Vollmer T; Knabbe C; Seifried E; Hourfar K; Lin CK; Spreafico M; Raffaele L; Berzuini A; Prati D; Satake M; de Korte D; van der Meer PF; Kerkhoffs JL; Blanco L; Kjeldsen-Kragh J; Svard-Nilsson AM; McDonald CP; Symonds I; Moule R; Brailsford S; Yomtovian R; Jacobs MR
    Vox Sang; 2014 Apr; 106(3):256-83. PubMed ID: 24654780
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.